Synthetic High-density Lipoprotein Nanodiscs for Personalized Immunotherapy Against Gliomas
Abstract
Gliomas are brain tumors with dismal prognoses. The standard-of-care treatments for gliomas include surgical resection, radiation, and temozolomide administration; however, they have been ineffective in providing significant increases in median survival. Antigen-specific cancer vaccines and immune checkpoint blockade may provide promising immunotherapeutic approaches for gliomas.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Aug 14, 2020
- Source ID
- 10.1158/1078-0432.ccr-20-0341
Entities
People
- Alireza Hassani Najafabadi
- Anna Schwendeman
- James J Moon
- Lindsay M Scheetz
- Maria G. Castro
- Marisa Aikins
- Padma Kadiyala
- Pedro R. Lowenstein
- Sejin Son
- Xiaoqi Sun
Organizations
- National Institutes of Health
- National Science Foundation
- United States Department of Defense
- University of Michigan